Dermata Therapeutics, Inc.
DRMA
$5.50
-$0.33-5.66%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -33.32% | 207.42% | -48.54% | 24.19% | 4.51% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -46.56% | -21.13% | -31.56% | 261.98% | -58.89% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 300.00% | -84.13% | -30.00% | -87.53% | 55.33% |
Total Current Assets | -33.63% | 183.11% | -47.16% | 27.70% | 1.10% |
|
|||||
Total Current Assets | -33.63% | 183.11% | -47.16% | 27.70% | 1.10% |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | -33.63% | 183.11% | -47.16% | 27.70% | 1.10% |
|
|||||
Total Accounts Payable | -70.35% | 72.69% | -6.44% | -34.93% | 61.36% |
Total Accrued Expenses | -53.18% | 12.34% | 7.60% | 83.10% | 7.65% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | -62.04% | 37.05% | 1.37% | 1.44% | 39.85% |
|
|||||
Total Current Liabilities | -62.04% | 37.05% | 1.37% | 1.44% | 39.85% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | -62.04% | 37.05% | 1.37% | 1.44% | 39.85% |
|
|||||
Common Stock & APIC | 0.02% | 11.96% | -0.04% | 7.33% | 3.88% |
Retained Earnings | -2.50% | -3.51% | -5.04% | -5.35% | -5.01% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -23.10% | 367.70% | -67.07% | 42.89% | -12.87% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -23.10% | 367.70% | -67.07% | 42.89% | -12.87% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -23.10% | 367.70% | -67.07% | 42.89% | -12.87% |
|